OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Greg Stanton (AZ04) disclosed a purchase $1K–$15K

Rep. Greg Stanton (AZ04) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
44 days
Disclosure lag
Traded
Sep 26, 2023
Disclosed
Nov 9, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 2, 2019CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. May 4, 2021CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  3. Jul 14, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  4. Aug 7, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Aug 10, 2023CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  6. Aug 22, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  7. Sep 7, 2023Congress · 2 peopleMembers of Congress: 2 purchases
  8. Sep 8, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  9. Sep 11, 2023CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  10. Sep 13, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  11. Sep 21, 2023CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  12. Sep 26, 2023 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Oct 16, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  2. Oct 24, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  3. Dec 5, 2023Congress · 2 peopleMembers of Congress: 2 purchases
  4. Dec 14, 2023Congress · 1 personMembers of Congress: 2 sales
  5. Dec 19, 2023FDAFDA drug approval: Erleada
  6. Dec 27, 2023FDARecall: Impella catheters - Intravascular micro axial blood pumps that support a patient's circulatory system. (1) Product Code 005042 - Impella 2.5 (2) Product Code 0…
  7. Dec 27, 2023FDARecall: Impella catheters - Intravascular micro axial blood pumps that support a patient's circulatory system. (1) Product Code 005042 - Impella 2.5 (2) Product Code 0…
  8. Jan 19, 2024FDAFDA drug approval: Balversa
  9. Jan 19, 2024FDAFDA drug approval: Balversa
  10. Jan 19, 2024FDAFDA device clearance: DePuy SUMMIT Porocoat Hip Prosthesis – MR Conditional, DePuy SUMMIT DuoFix Hip Prosthesis – MR Conditional, DePuy SUMMIT Cemented Hip Prosthesis – MR Condition…
  11. Jan 19, 2024Congress · 1 personMembers of Congress: 2 sales
  12. Jan 24, 2024FDARecall: Opal, Intervertebral Cage, 10x32mm, h 11mm, Revolvable-Indicated for degenerative spine disease Part Number: 08.803.231S
  13. Jan 24, 2024FDARecall: RAPIDSORB IPS Battery Pack, Sterile-Intended for use in non-load bearing fracture repair and reconstructive procedures of the craniofacial skeleton (excluding…
  14. Jan 24, 2024FDARecall: 13 mm Titanium Hindfoot Arthrodesis Cannulated Nails EX, sterile -Intended to facilitate tibiotalocalcaneal arthrodesis to treat severe foot/ankle deformity, a…
  15. Jan 24, 2024FDARecall: TFNA Femoral Nail 9mm, right, 130¿, L 235mm-Intended for temporary fixation and stabilization of proximal femur fractures. Part Number: 04.037.944S
  16. Jan 24, 2024FDARecall: 1.5MM Drill Bit/QC/85MM Sterile-surgical, orthopedic, pneumatic powered & accessory/attachment Part Number: 310.15S
  17. Jan 24, 2024FDARecall: VA-LCP Clavicle Plate 2.7, shaft, CS1, right-Intended for fixation of clavicle bone fragments. Part Number: 02.112.621S
  18. Jan 24, 2024FDARecall: 2.5MM DRILL BIT/QC/GOLD/110MM STERILE-surgical, orthopedic, pneumatic powered & accessory/attachment Product Code: 310.25S
  19. Jan 24, 2024FDARecall: RIA Tube Assembly, minimum 520 mm length, sterile- intended for use in adults and adolescents (12-21 years) to clear the medullary canal of bone marrow and deb…
  20. Jan 24, 2024FDARecall: TFNA Femoral Nail 11mm, right, 130¿, L 235mm-Intended for temporary fixation and stabilization of proximal femur fractures. Part Number: 04.037.144S
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Greg Stanton (AZ04)

The full history of Rep. Greg Stanton (AZ04) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data